Scarica l'app Stockscreener
3.204
2.36%
0.074
Precedente Chiudi:
$3.13
Aprire:
$3.1035
Volume 24 ore:
4,424
Relative Volume:
0.15
Capitalizzazione di mercato:
$5.73M
Reddito:
$770.00K
Utile/perdita netta:
$-38.84M
Rapporto P/E:
-0.2256
EPS:
-14.2049
Flusso di cassa netto:
$-43.02M
1 W Prestazione:
-16.78%
1M Prestazione:
-52.81%
6M Prestazione:
-31.83%
1 anno Prestazione:
-64.77%
Intervallo 1D:
$3.1035
$3.24
Intervallo di 1 settimana:
$3.1035
$3.9899
Portata 52W:
$3.1035
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Nome
Lyra Therapeutics Inc
Settore
Industria
Telefono
617-373-4600
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Confronta LYRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
3.23 | 5.56M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.34 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.80 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
919.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.60 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-06 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Ripresa | BTIG Research | Buy |
| 2023-08-31 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Iniziato | BTIG Research | Buy |
| 2020-05-26 | Iniziato | BofA/Merrill | Buy |
| 2020-05-26 | Iniziato | Jefferies | Buy |
| 2020-05-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com
What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com
What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com
What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com
Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de
PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus
What indicators show strength in Lyra Therapeutics Inc.2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Major Shareholder Sells Thousands of Lyra Therapeutics Shares! - TipRanks
BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results - Investing.com Canada
Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks - TipRanks
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lyra Therapeutics Inc Azioni (LYRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 12 '25 |
Sale |
4.06 |
8,745 |
35,499 |
17,239 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 11 '25 |
Sale |
4.31 |
5,320 |
22,954 |
18,122 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 06 '25 |
Sale |
5.18 |
32,149 |
166,529 |
22,521 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 07 '25 |
Sale |
4.75 |
19,739 |
93,695 |
20,528 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 10 '25 |
Sale |
4.54 |
18,502 |
83,995 |
18,659 |
1.07%
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):